Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

452
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
452
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

477
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
477
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

340
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
340
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

4.4K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
4.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

53
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recruitment strategies for lung cancer screening; a randomised trial in the 4-IN-THE-LUNG-RUN study.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of <i>MUC1</i> Genotype.

Journal of clinical medicine·2026
Same author

Follow-Up Care After Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries.

Respiration; international review of thoracic diseases·2026
Same author

[Documentation of biological treatment in asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction.

Chronic respiratory disease·2026
Same author

[Clinical and economic role of FeNO measurements in adults with asthma].

Pneumologie (Stuttgart, Germany)·2026
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Related Experiment Video

Updated: Sep 26, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.3K

[Sarcoidosis].

Julia Wälscher, Thomas E Wessendorf, Kaid Darwiche

    Pneumologie (Stuttgart, Germany)
    |April 22, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Sarcoidosis is a systemic granulomatous disease primarily affecting the lungs. Diagnosis relies on clinical, radiological, and histological findings, with treatment focusing on immunosuppressants when symptoms are severe or organs are affected.

    More Related Videos

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
    07:02

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

    Published on: September 14, 2010

    12.8K
    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    7.1K

    Related Experiment Videos

    Last Updated: Sep 26, 2025

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    20.3K
    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
    07:02

    Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

    Published on: September 14, 2010

    12.8K
    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    7.1K

    Area of Science:

    • Immunology
    • Pulmonology
    • Rheumatology

    Background:

    • Sarcoidosis is a multisystem granulomatous disease of unknown cause.
    • It commonly affects the lungs and thoracic lymph nodes.
    • Diagnosis involves clinical, radiological, and histological evidence of noncaseating granulomas.

    Purpose of the Study:

    • To summarize the diagnostic criteria for sarcoidosis.
    • To outline indications for therapeutic intervention.
    • To review current treatment recommendations for sarcoidosis.

    Main Methods:

    • Review of clinical, radiological, and histological diagnostic features.
    • Assessment of criteria for initiating therapy.
    • Evaluation of current international guidelines for immunosuppressive drug use.

    Main Results:

    • Diagnosis is established through clinical presentation, imaging, and biopsy showing noncaseating epithelioid granulomas.
    • Therapy is indicated for functional impairment, significant symptoms, or life-threatening organ involvement.
    • No specific drug is approved; immunosuppressants like glucocorticosteroids, methotrexate, azathioprine, or mycophenolate mofetil are recommended.

    Conclusions:

    • Sarcoidosis diagnosis requires a combination of findings.
    • Treatment decisions are guided by disease severity and organ involvement.
    • Current management relies on established immunosuppressive therapies.